+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Breast Cancer Imaging Market Size, Share & Trends Analysis Report by Stage of Care (Diagnostic, Monitoring), End Use (Hospitals, Breast Care Centers), Technology and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 140 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 6214524
REQUEST CUSTOMIZATION
Description Jump to:
The global breast cancer imaging market size was estimated at USD 2.1 billion in 2024 and is projected to reach USD 4.0 billion by 2033, growing at a CAGR of 7.7% from 2025 to 2033. This growth is attributed to increasing breast cancer awareness, technological advancements, rising incidence rates, and growing government and healthcare initiatives. Breast cancer is the most common type of cancer among women globally.

In the U.S. alone, an estimated 316,950 women are expected to be diagnosed with invasive breast cancer in 2025, along with 59,080 new cases of ductal carcinoma in situ (DCIS), a non-invasive form of the disease. This tendency is forecasted to escalate, for instance, the article by the Lancet Oncology states that global breast cancer incidence is expected to increase by 38% and related deaths by 68% by 2050, highlighting the need for early detection and tracking.

In the U.S., breast cancer is the second most common cancer and the second most common cause of cancer death among women. Contributing factors to the global rise of breast cancer include genetic risk factors, like the BRCA1 and BRCA2 mutations, and lifestyle factors like obesity, poor diet, sedentary lifestyle, smoking, and alcohol consumption. With the escalating severity of this situation, there is an urgent need for effective breast cancer imaging technologies to support timely diagnosis, assess the disease process accurately, and improve patient outcomes, which are crucial for reducing breast cancer mortality rates and managing the global rise in cases.

Technological advancement is another driving factor for the market, leading to a demand for improved diagnostic modalities. While traditional methods like mammography have been the foundation for breast cancer screening, emerging technologies are now complementing these approaches for high-risk populations and dense breast tissue. For example, tomosynthesis (3D mammography) has reduced breast tissue overlap artifacts, increasing cancer detection by 30-40% and decreasing recall rates. Contrast-enhanced spectral mammography (CESM) uses iodine contrast to visualize tumor vascularization in the breast. It performs with diagnostic accuracy like breast MRI for intraductal and lobular carcinomas and for occult lesions. In addition, automated 3D ultrasounds improve reproducibility and detect mammographically occult cancers. Contrast-enhanced ultrasound (CEUS) utilizes microbubbles to enhance the detection of tumor vascularity, similarly to CESM.

In addition, Government and healthcare initiatives contribute to the growth of breast cancer imaging in multiple areas, especially by improving early detection, ensuring screening access, and driving technological innovation. For instance, the National Health Mission (NHM) by the Indian government announced several national programs aimed at tackling breast cancer. The program includes comprehensive breast screening for individuals aged 30+, at Ayushman Arogya Mandirs, with over 14 crore women screened for breast cancer sc. Moreover, the government has approved the establishment of 19 state cancer institutes and 20 tertiary cancer care centers to improve tertiary-level cancer care. Similarly, the U.S. has implemented the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) to provide free or low-cost breast and cervical cancer screening and diagnostic services for uninsured or underinsured women. Furthermore, the Centers for Disease Control and Prevention (CDC) collaborates with public, non-profit, and private partners to address breast cancer in women under 45, focusing on prevention, early detection, and education. In addition, the UK government has started a breast screening program, inviting all women aged 50 to 71 to be screened with mammography on a three-yearly basis. The National Health Service Breast Screening Programme supports women in being informed and involved in decision-making around their screening options. These systems of governmental and healthcare-led intervention combine to stimulate demand for technologies that can advance the imaging of breast cancer, thus enabling earlier diagnosis and better outcomes for patients globally.

Global Breast Cancer Imaging Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global breast cancer imaging market report based on technology, stage of care, end-use, and region:

Technology Outlook (Revenue, USD Million, 2021-2033)

  • Mammography System (2D,3D)
  • Magnetic Resonance Imaging (MRI)-based systems
  • Nuclear Medicine- Based Systems
  • Ultrasound-Based Systems
  • Image-guided Biopsy
  • Others

Stage of Care Outlook (Revenue, USD Million, 2021-2033)

  • Diagnostics
  • Pre-treatment Planning
  • Monitoring
  • Surveillance (Follow-Up)

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Diagnostic Imaging Centers
  • Breast Care Centers
  • Others

Region Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Stage of Care
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Stage of Care outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Breast Cancer Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Incidence of Breast Cancer
3.2.1.2. Technological Advancements
3.2.1.3. Increasing Government and Healthcare Initiatives
3.2.2. Market Restraint Analysis
3.2.2.1. High Equipment Costs
3.2.2.2. Limited Health Care Access
3.3. Breast Cancer Imaging Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Breast Cancer Imaging Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Breast Cancer Imaging Market: Technology Movement Analysis
4.3. Breast Cancer Imaging Market by Technology Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
4.5. Mammography System (2D,3D)
4.5.1. Mammography System (2D,3D) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Magnetic Resonance Imaging (MRI)-based Systems
4.6.1. Magnetic Resonance Imaging (MRI)-based Systems Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.7. Nuclear Medicine- Based Systems
4.7.1. Nuclear Medicine-Based Systems Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.8. Ultrasound-Based Systems
4.8.1. Ultrasound-Based Systems Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.9. Image-guided Biopsy
4.9.1. Image-guided Biopsy Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.10. Others
4.10.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Breast Cancer Imaging Market: Stage of Care Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Breast Cancer Imaging Market: Stage of Care Movement Analysis
5.3. Breast Cancer Imaging Market by Stage of Care Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
5.5. Diagnostics
5.5.1. Diagnostics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Pre-treatment Planning
5.6.1. Pre-treatment Planning Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Monitoring
5.7.1. Monitoring Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Surveillance (Follow-Up)
5.8.1. Surveillance (Follow-Up) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Breast Cancer Imaging Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Breast Cancer Imaging Market: End Use Movement Analysis
6.3. Breast Cancer Imaging Market by End Use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Diagnostic Imaging Centers
6.6.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Breast Care Centers
6.7.1. Breast Care Centers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Others
6.8.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Breast Cancer Imaging Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional Breast Cancer Imaging Market Movement Analysis
7.3. Breast Cancer Imaging Market: Regional Estimates & Trend Analysis by Technology & End Use
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
7.5. North America
7.5.1. North America Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement scenario
7.5.2.5. U.S. Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Canada Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Mexico Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Europe
7.6.1. Europe Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.2. UK
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement scenario
7.6.2.5. UK Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.3. Germany
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Germany Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.4. France
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement scenario
7.6.4.5. France Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.5. Italy
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement scenario
7.6.5.5. Italy Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.6. Spain
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Spain Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.7. Denmark
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Denmark Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.8. Sweden
7.6.8.1. Key Country Dynamics
7.6.8.2. Competitive Scenario
7.6.8.3. Regulatory Framework
7.6.8.4. Reimbursement scenario
7.6.8.5. Sweden Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.9. Norway
7.6.9.1. Key Country Dynamics
7.6.9.2. Competitive Scenario
7.6.9.3. Regulatory Framework
7.6.9.4. Reimbursement scenario
7.6.9.5. Norway Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Asia-Pacific
7.7.1. Asia-Pacific Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.2. Japan
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Japan Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.3. China
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement scenario
7.7.3.5. China Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.4. India
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. Reimbursement scenario
7.7.4.5. India Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.5. South Korea
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Reimbursement scenario
7.7.5.5. South Korea Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.6. Australia
7.7.6.1. Key Country Dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory Framework
7.7.6.4. Reimbursement scenario
7.7.6.5. Australia Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.7. Thailand
7.7.7.1. Key Country Dynamics
7.7.7.2. Competitive Scenario
7.7.7.3. Regulatory Framework
7.7.7.4. Reimbursement scenario
7.7.7.5. Thailand Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8. Latin America
7.8.1. Latin America Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.2. Brazil
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement scenario
7.8.2.5. Brazil Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.3. Argentina
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Argentina Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.9. Middle East & Africa
7.9.1. Middle East & Africa Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.9.2. South Africa
7.9.2.1. Key Country Dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory Framework
7.9.2.4. Reimbursement scenario
7.9.2.5. South Africa Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.9.3. Saudi Arabia
7.9.3.1. Key Country Dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory Framework
7.9.3.4. Reimbursement scenario
7.9.3.5. Saudi Arabia Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.9.4. UAE
7.9.4.1. Key Country Dynamics
7.9.4.2. Competitive Scenario
7.9.4.3. Regulatory Framework
7.9.4.4. Reimbursement scenario
7.9.4.5. UAE Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
7.9.5. Kuwait
7.9.5.1. Key Country Dynamics
7.9.5.2. Competitive Scenario
7.9.5.3. Regulatory Framework
7.9.5.4. Reimbursement scenario
7.9.5.5. Kuwait Breast Cancer Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. GE Healthcare
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Hologic Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Siemens Healthcare
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Philips Healthcare
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Delphinus Medical Technologies
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Trivitron Healthineers
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Aurora Imaging Technology Inc.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Micrima Limited
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. QT Ultrasound LLC
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Fujifilm
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 4. Global Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 5. Global Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 6. North America Breast Cancer Imaging Market, by region, 2021-2033 (USD Million)
Table 7. North America Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 8. North America Breast Cancer Imaging Market, by Stage of Care, 2021-2033, (USD Million)
Table 9. North America Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 10. U.S. Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 11. U.S. Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 12. U.S. Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 13. Canada Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 14. Canada Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 15. Canada Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 16. Mexico Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 17. Mexico Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 18. Mexico Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 19. Europe Breast Cancer Imaging Market, by Country, 2021-2033 (USD Million)
Table 20. Europe Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 21. Europe Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 22. Europe Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 23. UK Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 24. UK Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 25. UK Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 26. Germany Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 27. Germany Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 28. Germany Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 29. France Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 30. France Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 31. France Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 32. Italy Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 33. Italy Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 34. Italy Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 35. Spain Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 36. Spain Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 37. Spain Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 38. Norway Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 39. Norway Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 40. Norway Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 41. Sweden Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 42. Sweden Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 43. Sweden Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 44. Denmark Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 45. Denmark Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 46. Denmark Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 47. Asia-Pacific Breast Cancer Imaging Market, by Country, 2021-2033 (USD Million)
Table 48. Asia-Pacific Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 49. Asia-Pacific Breast Cancer Imaging Market, by Application, 2021-2033 (USD Million)
Table 50. Asia-Pacific Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 51. Japan Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 52. Japan Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 53. Japan Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 54. China Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 55. China Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 56. China Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 57. India Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 58. India Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 59. India Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 60. Australia Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 61. Australia Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 62. Australia Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 63. South Korea Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 64. South Korea Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 65. Thailand Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 66. Thailand Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 67. Thailand Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 68. Latin America Breast Cancer Imaging Market, by Country, 2021-2033 (USD Million)
Table 69. Latin America Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 70. Latin America Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 71. Latin America Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 72. Brazil Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 73. Brazil Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 74. Brazil Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 75. Argentina Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 76. Argentina Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 77. Argentina Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 78. Middle East & Africa Breast Cancer Imaging Market, by Country, 2021-2033 (USD Million)
Table 79. Middle East & Africa Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 80. Middle East & Africa Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 81. Middle East & Africa Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 82. South Africa Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 83. South Africa Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 84. South Africa Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 85. Saudi Arabia Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 86. Saudi Arabia Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 87. Saudi Arabia Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 88. UAE Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 89. UAE Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 90. UAE Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
Table 91. Kuwait Breast Cancer Imaging Market, by Technology, 2021-2033 (USD Million)
Table 92. Kuwait Breast Cancer Imaging Market, by Stage of Care, 2021-2033 (USD Million)
Table 93. Kuwait Breast Cancer Imaging Market, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Information Procurement
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Breast Cancer Imaging market segmentation
Figure 7 Market driver analysis (Current & future impact)
Figure 8 Market restraint analysis (Current & future impact)
Figure 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 10 Porter’s Five Forces Analysis
Figure 11 Breast Cancer Imaging market, technology outlook key takeaways (USD Million)
Figure 12 Breast Cancer Imaging market: technology movement analysis 2024 & 2033 (USD Million)
Figure 13 Mammography Systems 2D, 3D) market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 14 Magnetic Resonance Imaging (MRI)-Based Systems market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 15 Nuclear Medicine-Based Systems market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 16 Ultrasound-Based Systems market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 17 Optical Imaging Systems market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 18 Image-guided Biopsy market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 19 Others market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 20 Breast Cancer Imaging market, Stage of Care outlook key takeaways (USD Million)
Figure 21 Breast Cancer Imaging market Stage of Care movement analysis 2024 & 2033 (USD Million)
Figure 22 Diagnostic market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Pre-treatment Planning market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Monitoring market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 25 Surveillance (Follow-Up) market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 26 Breast Cancer Imaging market, End Use outlook key takeaways (USD Million)
Figure 27 Breast Cancer Imaging market End Use movement analysis 2024 & 2033 (USD Million)
Figure 28 Hospitals’ market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Diagnostic Imaging Centers market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Breast Care Centers market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 31 Others market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 32 Breast Cancer Imaging market: Regional key takeaways (USD Million)
Figure 33 Breast Cancer Imaging market regional outlook, 2024 & 2033 (USD Million)
Figure 34 North America Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 U.S. Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 36 Canada Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Mexico Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Europe Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 UK Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 Germany Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 41 France Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 Spain Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Italy Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Sweden Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Norway Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 46 Denmark Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Asia-Pacific Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 China Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 49 Japan Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 50 India Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 South Korea Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Australia Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 Thailand Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Latin America Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Brazil Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 56 Argentina Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 57 Middle East and Africa Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 58 South Africa Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 Saudi Arabia Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 60 UAE Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Kuwait Breast Cancer Imaging market estimates and forecasts, 2021-2033 (USD Million)
Figure 62 List of key emerging company’s/indication disruptors/innovators

Companies Mentioned

The key companies profiled in this Breast Cancer Imaging market report include:
  • GE Healthcare
  • Hologic Inc.
  • Siemens healthcare
  • Philips Healthcare
  • Delphinus Medical Technologies
  • Trivitron Healthineers
  • Aurora Imaging Technology Inc.
  • Micrima Limited
  • QT Ultrasound LLC
  • Fujifilm

Table Information

Report AttributeDetails
No. of Pages140
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 2.1 Billion
Forecasted Market Value ( USD ) by 2033 $ 4 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

U.S. Breast Cancer Imaging Market Size, Share & Trends Analysis Report by Technology (Mammography System (2D, 3D)), Magnetic Resonance Imaging (MRI)-based Systems), Stage of Care (Diagnostic, Pre-treatment Planning), End-use and Region with Growth Forecasts, 2025-2033 - Product Image

U.S. Breast Cancer Imaging Market Size, Share & Trends Analysis Report by Technology (Mammography System (2D, 3D)), Magnetic Resonance Imaging (MRI)-based Systems), Stage of Care (Diagnostic, Pre-treatment Planning), End-use and Region with Growth Forecasts, 2025-2033

  • Report
  • 125 Pages
  • United States
From
Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 130 Pages
  • Global
From
Middle East Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Blood Tests), Application, End Use, and Country with Growth Forecasts, 2025-2033 - Product Image

Middle East Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Blood Tests), Application, End Use, and Country with Growth Forecasts, 2025-2033

  • Report
  • 130 Pages
  • Middle East
From
U.S. Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, and Growth Forecasts, 2025-2033 - Product Image

U.S. Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, and Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • United States
From
Breast Imaging Market Size, Share, Trends and Forecast by Technology, End User, and Region, 2025-2033 - Product Image

Breast Imaging Market Size, Share, Trends and Forecast by Technology, End User, and Region, 2025-2033

  • Report
  • 119 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.